These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 14556226)
61. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952 [TBL] [Abstract][Full Text] [Related]
62. Arsenic: toxicity, oxidative stress and human disease. Jomova K; Jenisova Z; Feszterova M; Baros S; Liska J; Hudecova D; Rhodes CJ; Valko M J Appl Toxicol; 2011 Mar; 31(2):95-107. PubMed ID: 21321970 [TBL] [Abstract][Full Text] [Related]
63. Cytotoxic, genotoxic and cell-cycle disruptive effects of thio-dimethylarsinate in cultured human cells and the role of glutathione. Ochi T; Kita K; Suzuki T; Rumpler A; Goessler W; Francesconi KA Toxicol Appl Pharmacol; 2008 Apr; 228(1):59-67. PubMed ID: 18207211 [TBL] [Abstract][Full Text] [Related]
64. Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Carew MW; Naranmandura H; Shukalek CB; Le XC; Leslie EM Drug Metab Dispos; 2011 Dec; 39(12):2298-304. PubMed ID: 21918036 [TBL] [Abstract][Full Text] [Related]
65. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder. Kinoshita A; Wanibuchi H; Wei M; Yunoki T; Fukushima S Toxicol Appl Pharmacol; 2007 Jun; 221(3):295-305. PubMed ID: 17481689 [TBL] [Abstract][Full Text] [Related]
66. Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells. Dodmane PR; Arnold LL; Kakiuchi-Kiyota S; Qiu F; Liu X; Rennard SI; Cohen SM Toxicology; 2013 Oct; 312():18-29. PubMed ID: 23876855 [TBL] [Abstract][Full Text] [Related]
67. Methylated trivalent arsenic species are genotoxic. Mass MJ; Tennant A; Roop BC; Cullen WR; Styblo M; Thomas DJ; Kligerman AD Chem Res Toxicol; 2001 Apr; 14(4):355-61. PubMed ID: 11304123 [TBL] [Abstract][Full Text] [Related]
68. Determination of trivalent methylated arsenicals in biological matrices. Del Razo LM; Styblo M; Cullen WR; Thomas DJ Toxicol Appl Pharmacol; 2001 Aug; 174(3):282-93. PubMed ID: 11485389 [TBL] [Abstract][Full Text] [Related]
69. Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Lu M; Wang H; Li XF; Lu X; Cullen WR; Arnold LL; Cohen SM; Le XC Chem Res Toxicol; 2004 Dec; 17(12):1733-42. PubMed ID: 15606151 [TBL] [Abstract][Full Text] [Related]
70. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235 [TBL] [Abstract][Full Text] [Related]
71. Methylated and thiolated arsenic species for environmental and health research - A review on synthesis and characterization. Cullen WR; Liu Q; Lu X; McKnight-Whitford A; Peng H; Popowich A; Yan X; Zhang Q; Fricke M; Sun H; Le XC J Environ Sci (China); 2016 Nov; 49():7-27. PubMed ID: 28007181 [TBL] [Abstract][Full Text] [Related]
72. Using mathematical modeling to infer the valence state of arsenicals in tissues: A PBPK model for dimethylarsinic acid (DMA Bilinsky LM; Thomas DJ; Fisher JW J Theor Biol; 2019 Jan; 461():215-229. PubMed ID: 30393109 [TBL] [Abstract][Full Text] [Related]
73. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. Tseng CH J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):1-22. PubMed ID: 17365340 [TBL] [Abstract][Full Text] [Related]
74. Distribution and metabolism of four different dimethylated arsenicals in hamsters. Naranmandura H; Iwata K; Suzuki KT; Ogra Y Toxicol Appl Pharmacol; 2010 May; 245(1):67-75. PubMed ID: 20144633 [TBL] [Abstract][Full Text] [Related]
75. Dimethylarsine and trimethylarsine are potent genotoxins in vitro. Andrewes P; Kitchin KT; Wallace K Chem Res Toxicol; 2003 Aug; 16(8):994-1003. PubMed ID: 12924927 [TBL] [Abstract][Full Text] [Related]
76. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Walton FS; Harmon AW; Paul DS; Drobná Z; Patel YM; Styblo M Toxicol Appl Pharmacol; 2004 Aug; 198(3):424-33. PubMed ID: 15276423 [TBL] [Abstract][Full Text] [Related]
77. Microbial transformation of arsenic species in municipal landfill leachate. Li Y; Low GK; Scott JA; Amal R J Hazard Mater; 2011 Apr; 188(1-3):140-7. PubMed ID: 21334808 [TBL] [Abstract][Full Text] [Related]
78. Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS. Kubachka KM; Kohan MC; Herbin-Davis K; Creed JT; Thomas DJ Toxicol Appl Pharmacol; 2009 Sep; 239(2):137-43. PubMed ID: 19133283 [TBL] [Abstract][Full Text] [Related]
79. Mechanisms of arsenic biotransformation. Vahter M Toxicology; 2002 Dec; 181-182():211-7. PubMed ID: 12505313 [TBL] [Abstract][Full Text] [Related]
80. Distribution and speciation of arsenic after intravenous administration of monomethylmonothioarsonic acid in rats. Naranmandura H; Bu N; Suzuki KT; Lou Y; Ogra Y Chemosphere; 2010 Sep; 81(2):206-13. PubMed ID: 20594576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]